von Willebrand disease (VWD)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Eligible patients diagnosed with von Willebrand disease (VWD). 2.The patient (or their legally authorized representative) has signed the informed consent form and agrees to participate in this study.
Exclusion criteria
Exclusion criteria: 1.Patients diagnosed with any other bleeding disorders. 2.Patients currently participating in other clinical studies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Treatment pattern;Patient-reported outcomes (PROs);Previous visiting departments;VWF antigen and activity levels, FIII levels and/or genetic test results at the time of previous diagnosis;Clinical disease subtype;Bleeding severity;VWF antigen and activity levels;Healthcare resource utilization; | — |
Countries
China
Contacts
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology